Figures & data
Figure 1 The screen process of the participants.
![Figure 1 The screen process of the participants.](/cms/asset/d4d5a989-2727-4ce4-b1fc-990e0e180f1e/djwh_a_12299875_f0001_c.jpg)
Table 1 Comparisons of the Characteristics of Alive and Dead Patients with Endometrial Carcinoma
Table 2 The Association of Survival of Patients with FIGO Staging
Figure 2 The Kaplan–Meier curve of endometrial carcinoma based on FIGO staging.
![Figure 2 The Kaplan–Meier curve of endometrial carcinoma based on FIGO staging.](/cms/asset/af7e78b8-3c3e-48f1-9ade-7986623cd6f5/djwh_a_12299875_f0002_c.jpg)
Table 3 Construction of the New Staging System
Table 4 The Association Between the New Staging with the Survival of Patients
Figure 3 The Kaplan–Meier curve of endometrial carcinoma based on new staging before (left) and after (right) combining overlap.
![Figure 3 The Kaplan–Meier curve of endometrial carcinoma based on new staging before (left) and after (right) combining overlap.](/cms/asset/b161444a-2fc9-46e7-90a7-93b36488aa18/djwh_a_12299875_f0003_c.jpg)
Table 5 Comparisons of the C-Index of FIGO Staging and New Staging
Table 6 Subgroup Analysis of the Survival of Endometrial Carcinoma Patients Using FIGO Staging and New Staging